FDA panel votes against approval of J&J arthritis drug

FDA panel votes against approval of J&J arthritis drug FDA panel votes against approval of J&J arthritis drug:- The benefits of Johnson & Johnson’s experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. The panel voted […]